Simplify complex tech into a named buyer narrative - problem, outcome, and business case - to overcome switching costs.
Most life science tools are complex, technical, and sold to skeptical, data-driven buyers. This conversation shows how to turn that complexity into a story scientists believe—without dumbing anything down. Matt Wilkinson and Jasmine Gruia-Gray speak with Bruce Scheer about simplifying solutions, naming your big ideas, and building a business case that wins over both scientists and the C-suite.
Who this is for: Biotech startup marketers and commercial leaders selling high-consideration solutions with multiple stakeholders and high switching costs.
What this covers: How to collapse sprawling product lines into a human-friendly solution map, craft a buyer-led narrative (Problem → Outcome → Solution), and back it up with economic proof. You’ll also hear why a shared narrative aligns sales and marketing, reduces buyer confusion, and boosts renewals—not just new deals.
KEY IDEA (suggested): Name and simplify your story—lead with the buyer’s problem, paint the desired outcome, then prove economic value to overcome switching pain.
What you will learn: